One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-129020
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 2 |
Affiliation: The University of Texas Health Science Center at San Antonio, Radboud University Nijmegen, Radboud University Nijmegen Medical Centre, University of Florence, Hôpital Saint-Louis, University of Insubria, Vrije Universiteit Amsterdam, Amsterdam University Medical Centers, University of Michigan–Ann Arbor, The University of Texas MD Anderson Cancer Center, Ithaka Harbors, Guy's and St Thomas' NHS Foundation TrustHealth-Related Quality of Life (HRQoL) in Patients with Myelofibrosis Treated with Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2 (JAK2), in the Randomized, Placebo-Controlled, Phase III JAKARTA Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
